This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash [Yahoo! Finance]
Biohaven Ltd. Common Shares (BHVN)
Last biohaven ltd. common shares earnings: 2/25 04:45 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.biohavenpharma.com
Company Research
Source: Yahoo! Finance
What happened According to a February 17, 2026, SEC filing , DAFNA Capital Management increased its position in Biohaven by 720,000 shares during the fourth quarter of 2025. The estimated value of this trade was $8.92 million, based on quarterly average pricing. The stake's total value at quarter-end was $10.78 million, up $7.25 million from the previous period, a change reflecting both the additional shares and movements in the stock's price. What else to know DAFNA's Biohaven position now represents 2.51% of its reportable U.S. equity assets after this buy. Top five holdings after the filing: NASDAQ:RVMD: $48.15 million (11.3% of AUM) NYSEMKT:XBI: $41.03 million (9.7% of AUM) NYSEMKT:STXS: $31.47 million (7.4% of AUM) NASDAQ:ATRC: $23.63 million (5.6% of AUM) NASDAQ:CYTK: $23.57 million (5.5% of AUM) As of Friday, Biohaven shares were priced at $8.93, down a staggering 68% over the past year and significantly underperforming the S&P 500, which is instead up abou
Show less
Read more
Impact Snapshot
Event Time:
BHVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHVN alerts
High impacting Biohaven Ltd. Common Shares news events
Weekly update
A roundup of the hottest topics
BHVN
News
- Mixed signals cloud the orphan drug market [Yahoo! Finance]Yahoo! Finance
- Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential [Yahoo! Finance]Yahoo! Finance
- Biohaven's Phase 2 Obesity Study with Taldefgrobep Alfa, a Novel Myostatin-Activin Pathway Inhibitor, Completes EnrollmentPR Newswire
- Biohaven (BHVN) had its price target raised by TD Cowen from $15.00 to $30.00. They now have a "buy" rating on the stock.MarketBeat
- Biohaven (BHVN) had its "strong-buy" rating reaffirmed by Raymond James Financial, Inc..MarketBeat
BHVN
Earnings
- 3/2/26 - Beat
BHVN
Sec Filings
- 3/19/26 - Form 4
- 3/13/26 - Form DEFA14A
- 3/13/26 - Form DEF
- BHVN's page on the SEC website